| 0 |
PROTEIN ALBUMIN RATIO DECREASED |
3 |
0.1364 |
| 1 |
DEATH OF PARENT |
1 |
0.0769 |
| 2 |
HEPATITIS NON-A NON-B |
1 |
0.0588 |
| 3 |
PSEUDOLOGIA |
1 |
0.0556 |
| 4 |
LABELLED DRUG-ALCOHOL INTERACTION ISSUE |
1 |
0.0526 |
| 5 |
MILK-ALKALI SYNDROME |
26 |
0.0497 |
| 6 |
LABELLED DRUG-FOOD INTERACTION ISSUE |
6 |
0.0353 |
| 7 |
ALCOHOL INTOLERANCE |
21 |
0.0296 |
| 8 |
CERULOPLASMIN INCREASED |
1 |
0.0286 |
| 9 |
INJECTION SITE ISCHAEMIA |
2 |
0.0278 |
| 10 |
SEPTIC PULMONARY EMBOLISM |
5 |
0.0256 |
| 11 |
TOXIC OPTIC NEUROPATHY |
11 |
0.0253 |
| 12 |
ENCEPHALITIS TOXIC |
2 |
0.0253 |
| 13 |
ALCOHOL TEST POSITIVE |
1 |
0.0213 |
| 14 |
ACUTE MOTOR AXONAL NEUROPATHY |
2 |
0.0192 |
| 15 |
NOCARDIA SEPSIS |
1 |
0.0185 |
| 16 |
SUBENDOCARDIAL ISCHAEMIA |
2 |
0.0180 |
| 17 |
MANIC SYMPTOM |
3 |
0.0179 |
| 18 |
SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE |
4 |
0.0174 |
| 19 |
VITAMIN B1 DECREASED |
4 |
0.0159 |
| 20 |
ILLOGICAL THINKING |
3 |
0.0159 |
| 21 |
CONFABULATION |
4 |
0.0151 |
| 22 |
OBSESSIVE RUMINATION |
1 |
0.0143 |
| 23 |
DISSOCIATIVE DISORDER |
10 |
0.0139 |
| 24 |
ACIDOSIS HYPERCHLORAEMIC |
8 |
0.0135 |
| 25 |
SINOBRONCHITIS |
2 |
0.0134 |
| 26 |
JARISCH-HERXHEIMER REACTION |
9 |
0.0126 |
| 27 |
OEDEMA DUE TO HEPATIC DISEASE |
1 |
0.0125 |
| 28 |
REDUCED FACIAL EXPRESSION |
12 |
0.0118 |
| 29 |
DYSKINESIA OESOPHAGEAL |
1 |
0.0112 |
| 30 |
DILATED PORES |
1 |
0.0110 |
| 31 |
NEONATAL RESPIRATORY DISTRESS |
10 |
0.0106 |
| 32 |
GENITAL PARAESTHESIA |
3 |
0.0103 |
| 33 |
DELUSION OF REPLACEMENT |
1 |
0.0100 |
| 34 |
CARDIAC INDEX DECREASED |
1 |
0.0097 |
| 35 |
MALE GENITAL ATROPHY |
1 |
0.0093 |
| 36 |
METABOLIC ALKALOSIS |
15 |
0.0093 |
| 37 |
ACUTE ON CHRONIC LIVER FAILURE |
2 |
0.0093 |
| 38 |
NEUROENDOCRINE TUMOUR OF THE LUNG |
1 |
0.0093 |
| 39 |
ALCOHOL WITHDRAWAL SYNDROME |
8 |
0.0092 |
| 40 |
GAMMA-GLUTAMYLTRANSFERASE |
1 |
0.0092 |
| 41 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
3 |
0.0090 |
| 42 |
ALCOHOL INTERACTION |
17 |
0.0087 |
| 43 |
ACUTE MOTOR-SENSORY AXONAL NEUROPATHY |
2 |
0.0087 |
| 44 |
MYOGLOBINAEMIA |
1 |
0.0085 |
| 45 |
INJECTION SITE GRANULOMA |
2 |
0.0084 |
| 46 |
NEUROBORRELIOSIS |
1 |
0.0076 |
| 47 |
MYOCARDIAL STUNNING |
1 |
0.0075 |
| 48 |
CALCIUM IONISED INCREASED |
1 |
0.0072 |
| 49 |
TOXIC ENCEPHALOPATHY |
36 |
0.0071 |
| 50 |
HYPOTENSIVE CRISIS |
1 |
0.0069 |
| 51 |
BRUCELLOSIS |
1 |
0.0066 |
| 52 |
HYPOTONIA NEONATAL |
10 |
0.0064 |
| 53 |
PSYCHIATRIC SYMPTOM |
44 |
0.0060 |
| 54 |
FOETAL CHROMOSOME ABNORMALITY |
1 |
0.0059 |
| 55 |
HEPATITIS CHRONIC ACTIVE |
1 |
0.0059 |
| 56 |
PH URINE INCREASED |
1 |
0.0058 |
| 57 |
TRI-IODOTHYRONINE DECREASED |
3 |
0.0057 |
| 58 |
DYSSOMNIA |
1 |
0.0052 |
| 59 |
PSYCHOTIC BEHAVIOUR |
5 |
0.0049 |
| 60 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
4 |
0.0049 |
| 61 |
THYROXINE DECREASED |
3 |
0.0048 |
| 62 |
KUSSMAUL RESPIRATION |
1 |
0.0048 |
| 63 |
INFLUENZA VIRUS TEST POSITIVE |
1 |
0.0047 |
| 64 |
PREGNANCY WITH INJECTABLE CONTRACEPTIVE |
1 |
0.0047 |
| 65 |
BELLIGERENCE |
2 |
0.0047 |
| 66 |
BLOOD ETHANOL INCREASED |
1 |
0.0045 |
| 67 |
BREATH ALCOHOL TEST POSITIVE |
1 |
0.0044 |
| 68 |
ANTICHOLINERGIC SYNDROME |
7 |
0.0044 |
| 69 |
LOCKED-IN SYNDROME |
2 |
0.0043 |
| 70 |
HYPOGONADISM MALE |
1 |
0.0043 |
| 71 |
CEREBRAL HYPOPERFUSION |
2 |
0.0043 |
| 72 |
CEREBELLAR ATAXIA |
4 |
0.0042 |
| 73 |
BLOOD BICARBONATE INCREASED |
2 |
0.0042 |
| 74 |
PCO2 DECREASED |
4 |
0.0041 |
| 75 |
MICROCYTOSIS |
1 |
0.0040 |
| 76 |
METASTASES TO THORAX |
1 |
0.0040 |
| 77 |
ANTIPSYCHOTIC DRUG LEVEL INCREASED |
11 |
0.0039 |
| 78 |
HEPATIC TRAUMA |
1 |
0.0039 |
| 79 |
AORTA HYPOPLASIA |
1 |
0.0038 |
| 80 |
ENDOCARDITIS BACTERIAL |
3 |
0.0038 |
| 81 |
HEMIANAESTHESIA |
3 |
0.0038 |
| 82 |
FOETAL ARRHYTHMIA |
1 |
0.0037 |
| 83 |
SPUTUM CULTURE POSITIVE |
3 |
0.0037 |
| 84 |
PERIPHERAL MOTOR NEUROPATHY |
5 |
0.0036 |
| 85 |
REPETITIVE SPEECH |
2 |
0.0036 |
| 86 |
ACUTE POLYNEUROPATHY |
1 |
0.0035 |
| 87 |
POST-INJECTION DELIRIUM SEDATION SYNDROME |
3 |
0.0035 |
| 88 |
AVERSION |
1 |
0.0035 |
| 89 |
AXONAL NEUROPATHY |
3 |
0.0034 |
| 90 |
PRODUCT RECONSTITUTION ISSUE |
1 |
0.0032 |
| 91 |
MAGNETIC RESONANCE IMAGING HEAD ABNORMAL |
2 |
0.0031 |
| 92 |
HEPATITIS ALCOHOLIC |
1 |
0.0031 |
| 93 |
METABOLIC SYNDROME |
5 |
0.0030 |
| 94 |
CHOLURIA |
1 |
0.0029 |
| 95 |
CRANIAL NERVE DISORDER |
2 |
0.0029 |
| 96 |
FIBROUS HISTIOCYTOMA |
1 |
0.0028 |
| 97 |
NEUROMUSCULAR TOXICITY |
1 |
0.0028 |
| 98 |
ANTIDEPRESSANT DRUG LEVEL INCREASED |
1 |
0.0028 |
| 99 |
ALKALOSIS |
1 |
0.0026 |
| 100 |
MACROCYTOSIS |
3 |
0.0026 |
| 101 |
ALCOHOLISM |
11 |
0.0026 |
| 102 |
BLOOD ALCOHOL INCREASED |
2 |
0.0026 |
| 103 |
LAGOPHTHALMOS |
1 |
0.0024 |
| 104 |
HYPOMANIA |
9 |
0.0024 |
| 105 |
PULMONARY CALCIFICATION |
1 |
0.0024 |
| 106 |
LYME DISEASE |
8 |
0.0024 |
| 107 |
DELUSIONAL DISORDER, PERSECUTORY TYPE |
1 |
0.0024 |
| 108 |
ALVEOLAR OSTEITIS |
1 |
0.0024 |
| 109 |
FRONTOTEMPORAL DEMENTIA |
1 |
0.0023 |
| 110 |
FOOD INTERACTION |
4 |
0.0023 |
| 111 |
CIRRHOSIS ALCOHOLIC |
1 |
0.0022 |
| 112 |
PRIMARY BILIARY CHOLANGITIS |
1 |
0.0021 |
| 113 |
PRE-EXISTING DISEASE |
1 |
0.0021 |
| 114 |
IDIOSYNCRATIC DRUG REACTION |
2 |
0.0020 |
| 115 |
HYPERCALCAEMIA |
25 |
0.0020 |
| 116 |
LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR |
1 |
0.0020 |
| 117 |
HEPATITIS ACUTE |
13 |
0.0020 |
| 118 |
HYPOHIDROSIS |
1 |
0.0020 |
| 119 |
PO2 INCREASED |
1 |
0.0020 |
| 120 |
POLYCYTHAEMIA |
4 |
0.0019 |
| 121 |
FOCAL NODULAR HYPERPLASIA |
1 |
0.0019 |
| 122 |
MALE ORGASMIC DISORDER |
1 |
0.0019 |
| 123 |
FRACTURE PAIN |
1 |
0.0019 |
| 124 |
RESPIRATORY ALKALOSIS |
3 |
0.0018 |
| 125 |
BRADYPHRENIA |
12 |
0.0018 |
| 126 |
BLOOD PH INCREASED |
1 |
0.0018 |
| 127 |
PRESBYOPIA |
1 |
0.0018 |
| 128 |
BRAIN SCAN ABNORMAL |
1 |
0.0018 |
| 129 |
NAIL DYSTROPHY |
1 |
0.0018 |
| 130 |
DYSPRAXIA |
1 |
0.0018 |
| 131 |
PO2 DECREASED |
2 |
0.0017 |
| 132 |
FLASHBACK |
1 |
0.0017 |
| 133 |
ISCHAEMIC CEREBRAL INFARCTION |
2 |
0.0017 |
| 134 |
PROTRUSION TONGUE |
1 |
0.0017 |
| 135 |
DISSOCIATION |
13 |
0.0017 |
| 136 |
AMBLYOPIA |
1 |
0.0017 |
| 137 |
ODYNOPHAGIA |
10 |
0.0017 |
| 138 |
HYPOVOLAEMIC SHOCK |
8 |
0.0017 |
| 139 |
HALLUCINATIONS, MIXED |
7 |
0.0017 |
| 140 |
GENERALISED TONIC-CLONIC SEIZURE |
27 |
0.0016 |
| 141 |
ALCOHOL USE |
6 |
0.0016 |
| 142 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
2 |
0.0016 |
| 143 |
ELECTROENCEPHALOGRAM ABNORMAL |
5 |
0.0016 |
| 144 |
INJECTION SITE LACERATION |
1 |
0.0016 |
| 145 |
PRESSURE OF SPEECH |
1 |
0.0015 |
| 146 |
HEPATITIS TOXIC |
4 |
0.0015 |
| 147 |
PSYCHOMOTOR SKILLS IMPAIRED |
4 |
0.0015 |
| 148 |
CATATONIA |
8 |
0.0015 |
| 149 |
COMPULSIONS |
1 |
0.0015 |
| 150 |
CATARACT NUCLEAR |
1 |
0.0015 |
| 151 |
ALCOHOL ABUSE |
4 |
0.0015 |
| 152 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
2 |
0.0015 |
| 153 |
CYTOKINE STORM |
1 |
0.0015 |
| 154 |
FEELING OF RELAXATION |
1 |
0.0015 |
| 155 |
PAINFUL ERECTION |
1 |
0.0014 |
| 156 |
ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0014 |
| 157 |
NUTRITIONAL CONDITION ABNORMAL |
1 |
0.0014 |
| 158 |
OPTIC NEUROPATHY |
3 |
0.0014 |
| 159 |
NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL |
2 |
0.0014 |
| 160 |
PERIPHERAL SENSORY NEUROPATHY |
8 |
0.0014 |
| 161 |
LEGAL PROBLEM |
1 |
0.0014 |
| 162 |
COMA HEPATIC |
1 |
0.0013 |
| 163 |
AMINO ACID LEVEL INCREASED |
1 |
0.0013 |
| 164 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
3 |
0.0013 |
| 165 |
AMPHETAMINES POSITIVE |
1 |
0.0013 |
| 166 |
MULTIPLE DRUG THERAPY |
1 |
0.0013 |
| 167 |
HEPATIC NECROSIS |
5 |
0.0013 |
| 168 |
MYOGLOBIN BLOOD INCREASED |
2 |
0.0013 |
| 169 |
ELECTROCARDIOGRAM PR PROLONGATION |
1 |
0.0013 |
| 170 |
METHAEMOGLOBINAEMIA |
3 |
0.0013 |
| 171 |
CRITICAL ILLNESS |
1 |
0.0013 |
| 172 |
SUBSTANCE USE |
2 |
0.0013 |
| 173 |
CHRONIC ALLOGRAFT NEPHROPATHY |
1 |
0.0013 |
| 174 |
DRUG-INDUCED LIVER INJURY |
40 |
0.0013 |
| 175 |
MYOCLONUS |
15 |
0.0013 |
| 176 |
POLYNEUROPATHY |
15 |
0.0013 |
| 177 |
STUPOR |
4 |
0.0012 |
| 178 |
DISINHIBITION |
2 |
0.0012 |
| 179 |
INTERVERTEBRAL DISC SPACE NARROWING |
1 |
0.0012 |
| 180 |
WRONG DOSE |
3 |
0.0012 |
| 181 |
CHRONIC HEPATITIS |
1 |
0.0012 |
| 182 |
PARKINSONISM |
12 |
0.0012 |
| 183 |
ELECTROCARDIOGRAM ST SEGMENT ABNORMAL |
1 |
0.0012 |
| 184 |
MITOCHONDRIAL TOXICITY |
1 |
0.0012 |
| 185 |
SOPOR |
16 |
0.0012 |
| 186 |
QUADRIPARESIS |
2 |
0.0012 |
| 187 |
NEUROLEPTIC MALIGNANT SYNDROME |
14 |
0.0012 |
| 188 |
SEIZURE LIKE PHENOMENA |
2 |
0.0012 |
| 189 |
SEDATION COMPLICATION |
3 |
0.0012 |
| 190 |
NOCARDIOSIS |
3 |
0.0012 |
| 191 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
2 |
0.0011 |
| 192 |
FOOD REFUSAL |
1 |
0.0011 |
| 193 |
DRUG DETOXIFICATION |
1 |
0.0011 |
| 194 |
VOCAL CORD PARALYSIS |
2 |
0.0011 |
| 195 |
ENCEPHALOPATHY |
27 |
0.0011 |
| 196 |
MANIA |
18 |
0.0011 |
| 197 |
ABULIA |
1 |
0.0011 |
| 198 |
BUNDLE BRANCH BLOCK |
1 |
0.0011 |
| 199 |
PSYCHOTIC DISORDER |
31 |
0.0010 |
| 200 |
CONCUSSION |
8 |
0.0010 |
| 201 |
HYPOKINESIA |
15 |
0.0010 |
| 202 |
ANIMAL SCRATCH |
1 |
0.0010 |
| 203 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
3 |
0.0010 |
| 204 |
HEPATITIS FULMINANT |
3 |
0.0010 |
| 205 |
MIXED LIVER INJURY |
3 |
0.0010 |
| 206 |
MUCOSAL DRYNESS |
2 |
0.0010 |
| 207 |
DYSPHORIA |
5 |
0.0010 |
| 208 |
INJECTION SITE NECROSIS |
2 |
0.0010 |
| 209 |
BREAST ABSCESS |
1 |
0.0010 |
| 210 |
NEUROTOXICITY |
17 |
0.0010 |
| 211 |
IMPAIRED SELF-CARE |
2 |
0.0010 |
| 212 |
POSTICTAL STATE |
1 |
0.0010 |
| 213 |
AXILLARY MASS |
1 |
0.0010 |
| 214 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
1 |
0.0009 |
| 215 |
ASTERIXIS |
1 |
0.0009 |
| 216 |
EXOPHTHALMOS |
2 |
0.0009 |
| 217 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
2 |
0.0009 |
| 218 |
INTENTIONAL SELF-INJURY |
18 |
0.0009 |
| 219 |
CYTOGENETIC ABNORMALITY |
1 |
0.0009 |
| 220 |
GASTROINTESTINAL BACTERIAL INFECTION |
1 |
0.0009 |
| 221 |
BUNDLE BRANCH BLOCK RIGHT |
4 |
0.0009 |
| 222 |
GRAND MAL CONVULSION |
8 |
0.0009 |
| 223 |
LUMBAR RADICULOPATHY |
1 |
0.0009 |
| 224 |
OSTEOCHONDROSIS |
1 |
0.0009 |
| 225 |
HANGOVER |
3 |
0.0009 |
| 226 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
8 |
0.0008 |
| 227 |
DELUSION |
13 |
0.0008 |
| 228 |
BONE LESION |
3 |
0.0008 |
| 229 |
CARDIAC DEATH |
1 |
0.0008 |
| 230 |
LIVER TRANSPLANT |
3 |
0.0008 |
| 231 |
HYPERACUSIS |
3 |
0.0008 |
| 232 |
THINKING ABNORMAL |
15 |
0.0008 |
| 233 |
INJECTION SITE ABSCESS |
2 |
0.0008 |
| 234 |
TACHYARRHYTHMIA |
2 |
0.0008 |
| 235 |
POISONING |
10 |
0.0008 |
| 236 |
BLOOD CREATINE PHOSPHOKINASE MB INCREASED |
1 |
0.0008 |
| 237 |
INFUSION SITE IRRITATION |
1 |
0.0008 |
| 238 |
GESTATIONAL HYPERTENSION |
1 |
0.0008 |
| 239 |
DRUG INTERACTION |
122 |
0.0008 |
| 240 |
ACQUIRED GENE MUTATION |
1 |
0.0008 |
| 241 |
AREFLEXIA |
2 |
0.0007 |
| 242 |
ANION GAP INCREASED |
1 |
0.0007 |
| 243 |
ALCOHOL POISONING |
2 |
0.0007 |
| 244 |
RESPIRATORY DEPRESSION |
9 |
0.0007 |
| 245 |
CARBON DIOXIDE INCREASED |
1 |
0.0007 |
| 246 |
ACUTE HEPATIC FAILURE |
10 |
0.0007 |
| 247 |
AGORAPHOBIA |
1 |
0.0007 |
| 248 |
CLONUS |
2 |
0.0007 |
| 249 |
SELF-MEDICATION |
3 |
0.0007 |
| 250 |
ACCIDENTAL POISONING |
1 |
0.0007 |
| 251 |
DISCHARGE |
1 |
0.0007 |
| 252 |
ELECTRIC SHOCK SENSATION |
2 |
0.0007 |
| 253 |
BRONCHIAL OBSTRUCTION |
1 |
0.0007 |
| 254 |
GLOMERULAR FILTRATION RATE ABNORMAL |
1 |
0.0007 |
| 255 |
EJACULATION DISORDER |
2 |
0.0007 |
| 256 |
PRECANCEROUS CELLS PRESENT |
1 |
0.0007 |
| 257 |
PERONEAL NERVE PALSY |
4 |
0.0007 |
| 258 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
1 |
0.0007 |
| 259 |
HORDEOLUM |
3 |
0.0007 |
| 260 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
3 |
0.0007 |
| 261 |
OCULAR ICTERUS |
3 |
0.0007 |
| 262 |
DELIRIUM |
24 |
0.0007 |
| 263 |
METABOLIC ENCEPHALOPATHY |
2 |
0.0007 |
| 264 |
MENTAL IMPAIRMENT |
16 |
0.0007 |
| 265 |
MYOCLONIC EPILEPSY |
1 |
0.0007 |
| 266 |
DRUG LEVEL ABOVE THERAPEUTIC |
3 |
0.0007 |
| 267 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0007 |
| 268 |
PORTAL HYPERTENSION |
2 |
0.0006 |
| 269 |
ELECTROCARDIOGRAM T WAVE ABNORMAL |
1 |
0.0006 |
| 270 |
PARANOIA |
11 |
0.0006 |
| 271 |
MEGACOLON |
1 |
0.0006 |
| 272 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA |
1 |
0.0006 |
| 273 |
OPTIC NERVE DISORDER |
1 |
0.0006 |
| 274 |
REFUSAL OF TREATMENT BY PATIENT |
4 |
0.0006 |
| 275 |
LISTLESS |
2 |
0.0006 |
| 276 |
LIVER FUNCTION TEST INCREASED |
13 |
0.0006 |
| 277 |
ILLUSION |
1 |
0.0006 |
| 278 |
IGA NEPHROPATHY |
1 |
0.0006 |
| 279 |
THERAPEUTIC AGENT TOXICITY |
2 |
0.0006 |
| 280 |
SALIVARY HYPERSECRETION |
6 |
0.0006 |
| 281 |
POTENTIATING DRUG INTERACTION |
2 |
0.0006 |
| 282 |
ATAXIA |
7 |
0.0006 |
| 283 |
FOOD AVERSION |
1 |
0.0006 |
| 284 |
NEUROPATHY |
1 |
0.0006 |
| 285 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
4 |
0.0006 |
| 286 |
HEPATIC FIBROSIS |
2 |
0.0006 |
| 287 |
ANURIA |
5 |
0.0006 |
| 288 |
DISORIENTATION |
23 |
0.0006 |
| 289 |
PRODUCT COUNTERFEIT |
1 |
0.0006 |
| 290 |
VIITH NERVE PARALYSIS |
2 |
0.0006 |
| 291 |
BLOOD CHLORIDE INCREASED |
1 |
0.0006 |
| 292 |
SLEEP APNOEA SYNDROME |
11 |
0.0006 |
| 293 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 294 |
SERUM FERRITIN INCREASED |
3 |
0.0006 |
| 295 |
NECROTISING FASCIITIS |
2 |
0.0006 |
| 296 |
NYSTAGMUS |
3 |
0.0006 |
| 297 |
PARAPARESIS |
1 |
0.0006 |
| 298 |
CONJUNCTIVAL HYPERAEMIA |
2 |
0.0006 |
| 299 |
BLOOD HIV RNA INCREASED |
1 |
0.0006 |
| 300 |
CONDUCTION DISORDER |
1 |
0.0005 |
| 301 |
INTRACRANIAL PRESSURE INCREASED |
3 |
0.0005 |
| 302 |
INJECTION SITE CELLULITIS |
1 |
0.0005 |
| 303 |
KETOACIDOSIS |
4 |
0.0005 |
| 304 |
NASAL OBSTRUCTION |
1 |
0.0005 |
| 305 |
DYSARTHRIA |
20 |
0.0005 |
| 306 |
DRUG ABUSE |
44 |
0.0005 |
| 307 |
MYELOPATHY |
1 |
0.0005 |
| 308 |
ACIDOSIS |
4 |
0.0005 |
| 309 |
COMMUNICATION DISORDER |
2 |
0.0005 |
| 310 |
SUICIDE ATTEMPT |
31 |
0.0005 |
| 311 |
HEPATOMEGALY |
5 |
0.0005 |
| 312 |
GENE MUTATION |
1 |
0.0005 |
| 313 |
MENTAL STATUS CHANGES |
14 |
0.0005 |
| 314 |
HEPATITIS CHOLESTATIC |
3 |
0.0005 |
| 315 |
FOAMING AT MOUTH |
1 |
0.0005 |
| 316 |
LIBIDO INCREASED |
1 |
0.0005 |
| 317 |
EPILEPSY |
15 |
0.0005 |
| 318 |
POLYURIA |
4 |
0.0005 |
| 319 |
EUGLYCAEMIC DIABETIC KETOACIDOSIS |
2 |
0.0005 |
| 320 |
FEAR |
13 |
0.0005 |
| 321 |
OLIGURIA |
3 |
0.0005 |
| 322 |
CHEST INJURY |
1 |
0.0005 |
| 323 |
BODY TEMPERATURE FLUCTUATION |
1 |
0.0005 |
| 324 |
METABOLIC ACIDOSIS |
15 |
0.0005 |
| 325 |
MYDRIASIS |
6 |
0.0005 |
| 326 |
PANIC ATTACK |
17 |
0.0005 |
| 327 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 328 |
HEPATIC FAILURE |
14 |
0.0005 |
| 329 |
INCOHERENT |
3 |
0.0005 |
| 330 |
JAW FRACTURE |
1 |
0.0005 |
| 331 |
FACIAL PALSY |
1 |
0.0005 |
| 332 |
URINE OUTPUT DECREASED |
4 |
0.0005 |
| 333 |
NOSOCOMIAL INFECTION |
1 |
0.0005 |
| 334 |
ELECTROCARDIOGRAM T WAVE INVERSION |
1 |
0.0005 |
| 335 |
STEVENS-JOHNSON SYNDROME |
10 |
0.0004 |
| 336 |
FAECES PALE |
1 |
0.0004 |
| 337 |
PARESIS |
1 |
0.0004 |
| 338 |
LARGE INTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 339 |
JAUNDICE |
12 |
0.0004 |
| 340 |
FEAR OF DEATH |
1 |
0.0004 |
| 341 |
HEPATOCELLULAR DAMAGE |
1 |
0.0004 |
| 342 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 343 |
VASCULAR DEVICE INFECTION |
2 |
0.0004 |
| 344 |
DRUG TOXICITY |
6 |
0.0004 |
| 345 |
PNEUMONIA ASPIRATION |
11 |
0.0004 |
| 346 |
URINE ABNORMALITY |
2 |
0.0004 |
| 347 |
MYOCARDIAL ISCHAEMIA |
5 |
0.0004 |
| 348 |
DENGUE FEVER |
1 |
0.0004 |
| 349 |
RESPIRATORY ARREST |
12 |
0.0004 |
| 350 |
COORDINATION ABNORMAL |
6 |
0.0004 |
| 351 |
HEPATIC ENCEPHALOPATHY |
4 |
0.0004 |
| 352 |
YELLOW SKIN |
2 |
0.0004 |
| 353 |
DYSMORPHISM |
1 |
0.0004 |
| 354 |
SINUS TACHYCARDIA |
6 |
0.0004 |
| 355 |
PRODUCT PRESCRIBING ERROR |
10 |
0.0004 |
| 356 |
LACUNAR INFARCTION |
1 |
0.0004 |
| 357 |
SEROTONIN SYNDROME |
8 |
0.0004 |
| 358 |
ORAL INTAKE REDUCED |
1 |
0.0004 |
| 359 |
MAJOR DEPRESSION |
3 |
0.0004 |
| 360 |
BREATH ODOUR |
1 |
0.0004 |
| 361 |
CEREBRAL DISORDER |
3 |
0.0004 |
| 362 |
ACUTE PSYCHOSIS |
1 |
0.0004 |
| 363 |
MULTIPLE DRUG OVERDOSE |
2 |
0.0004 |
| 364 |
INJECTION SITE INFLAMMATION |
2 |
0.0004 |
| 365 |
PREMATURE BABY |
12 |
0.0004 |
| 366 |
EXPOSURE VIA INGESTION |
1 |
0.0004 |
| 367 |
DIABETIC COMPLICATION |
1 |
0.0004 |
| 368 |
AMMONIA INCREASED |
2 |
0.0004 |
| 369 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 370 |
EUPHORIC MOOD |
4 |
0.0004 |
| 371 |
ENDOCARDITIS |
2 |
0.0004 |
| 372 |
DISTURBANCE IN ATTENTION |
21 |
0.0004 |
| 373 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 374 |
TOXICITY TO VARIOUS AGENTS |
65 |
0.0004 |
| 375 |
POSTMENOPAUSAL HAEMORRHAGE |
1 |
0.0004 |
| 376 |
AFFECTIVE DISORDER |
3 |
0.0004 |
| 377 |
DRUG SCREEN POSITIVE |
3 |
0.0004 |
| 378 |
MIOSIS |
3 |
0.0004 |
| 379 |
ANAESTHETIC COMPLICATION |
1 |
0.0004 |
| 380 |
CLUMSINESS |
1 |
0.0004 |
| 381 |
CHOKING SENSATION |
2 |
0.0004 |
| 382 |
DRUG LEVEL INCREASED |
6 |
0.0004 |
| 383 |
ACUTE CORONARY SYNDROME |
3 |
0.0004 |
| 384 |
RHABDOMYOLYSIS |
15 |
0.0004 |
| 385 |
DEPRESSED MOOD |
19 |
0.0004 |
| 386 |
HAEMODIALYSIS |
3 |
0.0004 |
| 387 |
PSYCHOMOTOR RETARDATION |
1 |
0.0004 |
| 388 |
PANCREATIC CARCINOMA METASTATIC |
1 |
0.0004 |
| 389 |
GRANULOCYTOPENIA |
2 |
0.0004 |
| 390 |
DRUG RESISTANCE |
9 |
0.0004 |
| 391 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
6 |
0.0003 |
| 392 |
CARDIOGENIC SHOCK |
5 |
0.0003 |
| 393 |
NEUROPATHY PERIPHERAL |
33 |
0.0003 |
| 394 |
MENTAL DISORDER |
15 |
0.0003 |
| 395 |
NECK INJURY |
1 |
0.0003 |
| 396 |
BONE MARROW DISORDER |
1 |
0.0003 |
| 397 |
AGITATION |
24 |
0.0003 |
| 398 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
3 |
0.0003 |
| 399 |
ALANINE AMINOTRANSFERASE INCREASED |
20 |
0.0003 |
| 400 |
FIBROSIS |
1 |
0.0003 |
| 401 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
2 |
0.0003 |
| 402 |
FAECES DISCOLOURED |
7 |
0.0003 |
| 403 |
INJECTION SITE HYPERSENSITIVITY |
1 |
0.0003 |
| 404 |
SUICIDAL IDEATION |
29 |
0.0003 |
| 405 |
BREAST CANCER RECURRENT |
1 |
0.0003 |
| 406 |
MULTIPLE DRUG OVERDOSE INTENTIONAL |
1 |
0.0003 |
| 407 |
DYSTONIA |
6 |
0.0003 |
| 408 |
LACTIC ACIDOSIS |
10 |
0.0003 |
| 409 |
VITAMIN D DEFICIENCY |
3 |
0.0003 |
| 410 |
OEDEMA MOUTH |
1 |
0.0003 |
| 411 |
RENAL TUBULAR NECROSIS |
3 |
0.0003 |
| 412 |
SEDATION |
8 |
0.0003 |
| 413 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 414 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
12 |
0.0003 |
| 415 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
1 |
0.0003 |
| 416 |
PSYCHOMOTOR HYPERACTIVITY |
5 |
0.0003 |
| 417 |
BRAIN INJURY |
3 |
0.0003 |
| 418 |
POST-TRAUMATIC STRESS DISORDER |
2 |
0.0003 |
| 419 |
METASTASES TO SPINE |
1 |
0.0003 |
| 420 |
CONFUSIONAL STATE |
48 |
0.0003 |
| 421 |
HYPOTHERMIA |
3 |
0.0003 |
| 422 |
DIABETIC RETINOPATHY |
1 |
0.0003 |
| 423 |
MOTOR DYSFUNCTION |
3 |
0.0003 |
| 424 |
COMA |
14 |
0.0003 |
| 425 |
CIRCULATORY COLLAPSE |
5 |
0.0003 |
| 426 |
AKATHISIA |
4 |
0.0003 |
| 427 |
BLOOD TESTOSTERONE DECREASED |
2 |
0.0003 |
| 428 |
INITIAL INSOMNIA |
3 |
0.0003 |
| 429 |
DIFFICULTY IN WALKING |
1 |
0.0003 |
| 430 |
LEFT VENTRICULAR FAILURE |
1 |
0.0003 |
| 431 |
MULTI-ORGAN FAILURE |
5 |
0.0003 |
| 432 |
DEPRESSION SUICIDAL |
1 |
0.0003 |
| 433 |
HYPERREFLEXIA |
1 |
0.0003 |
| 434 |
CAROTID ARTERY STENOSIS |
1 |
0.0003 |
| 435 |
LIVER INJURY |
7 |
0.0003 |
| 436 |
JAUNDICE CHOLESTATIC |
1 |
0.0003 |
| 437 |
FACIAL PARESIS |
1 |
0.0003 |
| 438 |
INTENTIONAL OVERDOSE |
18 |
0.0003 |
| 439 |
COGNITIVE DISORDER |
13 |
0.0003 |
| 440 |
PARADOXICAL DRUG REACTION |
1 |
0.0003 |
| 441 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
6 |
0.0003 |
| 442 |
CARDIAC DYSFUNCTION |
1 |
0.0003 |
| 443 |
MALNUTRITION |
3 |
0.0003 |
| 444 |
HEPATIC CIRRHOSIS |
5 |
0.0003 |
| 445 |
ASPARTATE AMINOTRANSFERASE INCREASED |
14 |
0.0003 |
| 446 |
TROPONIN INCREASED |
2 |
0.0003 |
| 447 |
CONVULSION |
15 |
0.0003 |
| 448 |
HYPERTHERMIA |
2 |
0.0003 |
| 449 |
PROCEDURAL COMPLICATION |
2 |
0.0003 |
| 450 |
OPTIC ISCHAEMIC NEUROPATHY |
1 |
0.0003 |
| 451 |
ELECTROLYTE IMBALANCE |
3 |
0.0003 |
| 452 |
POLYDIPSIA |
1 |
0.0003 |
| 453 |
ABNORMAL BEHAVIOUR |
10 |
0.0003 |
| 454 |
HALLUCINATION, AUDITORY |
4 |
0.0003 |
| 455 |
OESOPHAGEAL CANDIDIASIS |
1 |
0.0003 |
| 456 |
INTRACRANIAL ANEURYSM |
1 |
0.0002 |
| 457 |
ENURESIS |
1 |
0.0002 |
| 458 |
GLOMERULAR FILTRATION RATE DECREASED |
3 |
0.0002 |
| 459 |
HYPERURICAEMIA |
1 |
0.0002 |
| 460 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
7 |
0.0002 |
| 461 |
COAGULOPATHY |
4 |
0.0002 |
| 462 |
CONGESTIVE CARDIOMYOPATHY |
1 |
0.0002 |
| 463 |
CARDIO-RESPIRATORY ARREST |
10 |
0.0002 |
| 464 |
ERECTION INCREASED |
1 |
0.0002 |
| 465 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 466 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 467 |
FACIAL PARALYSIS |
2 |
0.0002 |
| 468 |
HEPATIC PAIN |
1 |
0.0002 |
| 469 |
IRRITABILITY |
14 |
0.0002 |
| 470 |
CARDIAC ARREST |
19 |
0.0002 |
| 471 |
SYNCOPE |
23 |
0.0002 |
| 472 |
PRODUCT DISPENSING ERROR |
5 |
0.0002 |
| 473 |
DYSPHEMIA |
1 |
0.0002 |
| 474 |
COMPLETED SUICIDE |
19 |
0.0002 |
| 475 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
2 |
0.0002 |
| 476 |
PURPURA |
2 |
0.0002 |
| 477 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 478 |
DRUG ERUPTION |
4 |
0.0002 |
| 479 |
RESPIRATORY RATE INCREASED |
2 |
0.0002 |
| 480 |
TRANSAMINASES INCREASED |
5 |
0.0002 |
| 481 |
CARDIOTOXICITY |
2 |
0.0002 |
| 482 |
ISCHAEMIC STROKE |
4 |
0.0002 |
| 483 |
ACUTE KIDNEY INJURY |
34 |
0.0002 |
| 484 |
TACHYPNOEA |
3 |
0.0002 |
| 485 |
OPTIC NEURITIS |
2 |
0.0002 |
| 486 |
PERIPHERAL COLDNESS |
3 |
0.0002 |
| 487 |
EAR DISORDER |
1 |
0.0002 |
| 488 |
ISCHAEMIA |
1 |
0.0002 |
| 489 |
SHOCK |
5 |
0.0002 |
| 490 |
INTERVERTEBRAL DISC DEGENERATION |
2 |
0.0002 |
| 491 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 492 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 493 |
PERFORMANCE STATUS DECREASED |
1 |
0.0002 |
| 494 |
RENAL FAILURE ACUTE |
9 |
0.0002 |
| 495 |
DIALYSIS |
3 |
0.0002 |
| 496 |
POISONING DELIBERATE |
2 |
0.0002 |
| 497 |
GESTATIONAL DIABETES |
1 |
0.0002 |
| 498 |
AFFECT LABILITY |
2 |
0.0002 |
| 499 |
APHAGIA |
1 |
0.0002 |
| 500 |
INJECTION SITE HAEMATOMA |
3 |
0.0002 |
| 501 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 502 |
APATHY |
3 |
0.0002 |
| 503 |
OVERDOSE |
44 |
0.0002 |
| 504 |
BODY TEMPERATURE DECREASED |
2 |
0.0002 |
| 505 |
TACHYCARDIA |
18 |
0.0002 |
| 506 |
ANEURYSM |
1 |
0.0002 |
| 507 |
APHASIA |
6 |
0.0002 |
| 508 |
OSTEOPENIA |
3 |
0.0002 |
| 509 |
TOXIC EPIDERMAL NECROLYSIS |
3 |
0.0002 |
| 510 |
HYPONATRAEMIA |
11 |
0.0002 |
| 511 |
EAR DISCOMFORT |
2 |
0.0002 |
| 512 |
MUSCULOSKELETAL CHEST PAIN |
3 |
0.0002 |
| 513 |
TREMOR |
32 |
0.0002 |
| 514 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 515 |
SPEECH DISORDER |
10 |
0.0002 |
| 516 |
HEPATIC ENZYME INCREASED |
13 |
0.0002 |
| 517 |
INCONTINENCE |
2 |
0.0002 |
| 518 |
INJECTION SITE REACTION |
13 |
0.0002 |
| 519 |
IMPAIRED WORK ABILITY |
4 |
0.0002 |
| 520 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 521 |
GINGIVITIS |
1 |
0.0002 |
| 522 |
ALTERED STATE OF CONSCIOUSNESS |
4 |
0.0002 |
| 523 |
HYDROCEPHALUS |
1 |
0.0002 |
| 524 |
OESOPHAGITIS |
2 |
0.0002 |
| 525 |
ASPIRATION |
2 |
0.0002 |
| 526 |
STAPHYLOCOCCAL INFECTION |
6 |
0.0002 |
| 527 |
INTESTINAL ISCHAEMIA |
1 |
0.0002 |
| 528 |
HEPATOTOXICITY |
4 |
0.0002 |
| 529 |
SOMNOLENCE |
36 |
0.0002 |
| 530 |
ANGIOPATHY |
1 |
0.0002 |
| 531 |
HEMIPARESIS |
3 |
0.0002 |
| 532 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 533 |
MITRAL VALVE INCOMPETENCE |
2 |
0.0002 |
| 534 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 535 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 536 |
MYOCARDITIS |
2 |
0.0002 |
| 537 |
LETHARGY |
10 |
0.0002 |
| 538 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 539 |
UPPER RESPIRATORY TRACT INFECTION |
8 |
0.0002 |
| 540 |
METABOLIC DISORDER |
1 |
0.0002 |
| 541 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 542 |
SEXUAL DYSFUNCTION |
2 |
0.0002 |
| 543 |
DECREASED INTEREST |
1 |
0.0002 |
| 544 |
LEUKOCYTOSIS |
3 |
0.0002 |
| 545 |
HEPATITIS C |
2 |
0.0002 |
| 546 |
HYPOGLYCAEMIA |
8 |
0.0002 |
| 547 |
SCHIZOPHRENIA |
2 |
0.0002 |
| 548 |
RESPIRATORY FAILURE |
12 |
0.0002 |
| 549 |
TREATMENT NONCOMPLIANCE |
9 |
0.0002 |
| 550 |
SEIZURE |
19 |
0.0002 |
| 551 |
CEREBRAL INFARCTION |
4 |
0.0002 |
| 552 |
CARDIOMEGALY |
2 |
0.0002 |
| 553 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 554 |
INJECTION SITE MASS |
6 |
0.0002 |
| 555 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 556 |
CONJUNCTIVITIS |
3 |
0.0002 |
| 557 |
EXTRAPYRAMIDAL DISORDER |
4 |
0.0002 |
| 558 |
NERVOUS SYSTEM DISORDER |
5 |
0.0002 |
| 559 |
MEMORY IMPAIRMENT |
22 |
0.0002 |
| 560 |
BLEPHAROSPASM |
1 |
0.0002 |
| 561 |
MULTIPLE INJURIES |
1 |
0.0002 |
| 562 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 563 |
ERECTILE DYSFUNCTION |
4 |
0.0002 |
| 564 |
INJECTION SITE INDURATION |
2 |
0.0002 |
| 565 |
DIPLOPIA |
4 |
0.0002 |
| 566 |
NODULE |
2 |
0.0002 |
| 567 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 568 |
GASTRITIS |
4 |
0.0002 |
| 569 |
DYSGRAPHIA |
1 |
0.0002 |
| 570 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 571 |
ANXIETY |
43 |
0.0002 |
| 572 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 573 |
APPETITE DISORDER |
1 |
0.0002 |
| 574 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 575 |
QUALITY OF LIFE DECREASED |
2 |
0.0001 |
| 576 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 577 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 578 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 579 |
DROOLING |
1 |
0.0001 |
| 580 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 581 |
FORMICATION |
1 |
0.0001 |
| 582 |
HUNGER |
2 |
0.0001 |
| 583 |
INTENTIONAL DRUG MISUSE |
3 |
0.0001 |
| 584 |
ROAD TRAFFIC ACCIDENT |
6 |
0.0001 |
| 585 |
HYPERKALAEMIA |
5 |
0.0001 |
| 586 |
OFF LABEL USE |
124 |
0.0001 |
| 587 |
EATING DISORDER |
3 |
0.0001 |
| 588 |
BRONCHOSPASM |
2 |
0.0001 |
| 589 |
AGGRESSION |
7 |
0.0001 |
| 590 |
PARALYSIS |
2 |
0.0001 |
| 591 |
IMPAIRED QUALITY OF LIFE |
2 |
0.0001 |
| 592 |
PARAESTHESIA ORAL |
2 |
0.0001 |
| 593 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 594 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 595 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 596 |
URINARY INCONTINENCE |
4 |
0.0001 |
| 597 |
ARTHROPOD BITE |
1 |
0.0001 |
| 598 |
RASH MACULO-PAPULAR |
3 |
0.0001 |
| 599 |
HEPATIC FUNCTION ABNORMAL |
5 |
0.0001 |
| 600 |
CHROMATURIA |
3 |
0.0001 |
| 601 |
LOSS OF CONSCIOUSNESS |
17 |
0.0001 |
| 602 |
PAROSMIA |
1 |
0.0001 |
| 603 |
CONTRAINDICATED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 604 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 605 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 606 |
MUSCLE TWITCHING |
3 |
0.0001 |
| 607 |
PHARYNGEAL OEDEMA |
2 |
0.0001 |
| 608 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 609 |
APHTHOUS ULCER |
1 |
0.0001 |
| 610 |
CYANOSIS |
2 |
0.0001 |
| 611 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 612 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 613 |
LOW BIRTH WEIGHT BABY |
1 |
0.0001 |
| 614 |
HYPOTENSION |
25 |
0.0001 |
| 615 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 616 |
MUSCLE DISORDER |
1 |
0.0001 |
| 617 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 618 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 619 |
AMNESIA |
8 |
0.0001 |
| 620 |
BLOOD CREATININE INCREASED |
8 |
0.0001 |
| 621 |
THERAPEUTIC RESPONSE SHORTENED |
4 |
0.0001 |
| 622 |
HEMIPLEGIA |
1 |
0.0001 |
| 623 |
INSOMNIA |
32 |
0.0001 |
| 624 |
BLOOD UREA INCREASED |
2 |
0.0001 |
| 625 |
CONDITION AGGRAVATED |
36 |
0.0001 |
| 626 |
HAEMATEMESIS |
3 |
0.0001 |
| 627 |
INADEQUATE ANALGESIA |
1 |
0.0001 |
| 628 |
UNRESPONSIVE TO STIMULI |
3 |
0.0001 |
| 629 |
INTENTIONAL PRODUCT USE ISSUE |
10 |
0.0001 |
| 630 |
DRUG WITHDRAWAL SYNDROME |
10 |
0.0001 |
| 631 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 632 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 633 |
LIVER DISORDER |
5 |
0.0001 |
| 634 |
THIRST |
2 |
0.0001 |
| 635 |
ELECTROCARDIOGRAM QT PROLONGED |
4 |
0.0001 |
| 636 |
LOSS OF LIBIDO |
1 |
0.0001 |
| 637 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 638 |
PALLOR |
3 |
0.0001 |
| 639 |
DEPRESSION |
25 |
0.0001 |
| 640 |
ACCIDENTAL OVERDOSE |
4 |
0.0001 |
| 641 |
RESPIRATORY DISTRESS |
3 |
0.0001 |
| 642 |
BLOOD GLUCOSE ABNORMAL |
2 |
0.0001 |
| 643 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 644 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 645 |
HEPATIC STEATOSIS |
2 |
0.0001 |
| 646 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 647 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 648 |
FLANK PAIN |
1 |
0.0001 |
| 649 |
FATIGUE |
83 |
0.0001 |
| 650 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 651 |
CHOLESTASIS |
2 |
0.0001 |
| 652 |
NEEDLE ISSUE |
3 |
0.0001 |
| 653 |
DYSSTASIA |
3 |
0.0001 |
| 654 |
HEART RATE INCREASED |
10 |
0.0001 |
| 655 |
BLADDER DISORDER |
1 |
0.0001 |
| 656 |
HYPOTONIA |
1 |
0.0001 |
| 657 |
OVARIAN CYST |
1 |
0.0001 |
| 658 |
THERAPEUTIC RESPONSE DECREASED |
6 |
0.0001 |
| 659 |
FOETAL EXPOSURE DURING PREGNANCY |
8 |
0.0001 |
| 660 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 661 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 662 |
MALIGNANT NEOPLASM PROGRESSION |
10 |
0.0001 |
| 663 |
DEHYDRATION |
13 |
0.0001 |
| 664 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
1 |
0.0001 |
| 665 |
INJECTION SITE WARMTH |
2 |
0.0001 |
| 666 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 667 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 668 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 669 |
HEAD INJURY |
3 |
0.0001 |
| 670 |
HALLUCINATION, VISUAL |
2 |
0.0001 |
| 671 |
MYALGIA |
16 |
0.0001 |
| 672 |
MOVEMENT DISORDER |
3 |
0.0001 |
| 673 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 674 |
HYPERHIDROSIS |
12 |
0.0001 |
| 675 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 676 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 677 |
BACK INJURY |
1 |
0.0001 |
| 678 |
INTENTIONAL PRODUCT MISUSE |
8 |
0.0001 |
| 679 |
DENTAL CARIES |
1 |
0.0001 |
| 680 |
ABDOMINAL PAIN |
21 |
0.0001 |
| 681 |
NERVE INJURY |
1 |
0.0001 |
| 682 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
0.0001 |
| 683 |
PRODUCT USE IN UNAPPROVED INDICATION |
22 |
0.0001 |
| 684 |
FLUSHING |
9 |
0.0001 |
| 685 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 686 |
TINNITUS |
4 |
0.0001 |
| 687 |
NIGHTMARE |
3 |
0.0001 |
| 688 |
METASTASES TO LUNG |
1 |
0.0001 |
| 689 |
HYPOXIA |
3 |
0.0001 |
| 690 |
INFLUENZA LIKE ILLNESS |
7 |
0.0001 |
| 691 |
CHOLECYSTITIS |
1 |
0.0001 |
| 692 |
ACCIDENT |
1 |
0.0001 |
| 693 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 694 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 695 |
BLOOD PRESSURE FLUCTUATION |
2 |
0.0001 |
| 696 |
DIABETIC KETOACIDOSIS |
2 |
0.0001 |
| 697 |
RENAL FAILURE |
11 |
0.0001 |
| 698 |
LOCALISED INFECTION |
2 |
0.0001 |
| 699 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 700 |
ASTHENIA |
31 |
0.0001 |
| 701 |
PRESYNCOPE |
2 |
0.0001 |
| 702 |
VERTIGO |
5 |
0.0001 |
| 703 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 704 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 705 |
OSTEONECROSIS OF JAW |
2 |
0.0001 |
| 706 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 707 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 708 |
ANOREXIA |
1 |
0.0001 |
| 709 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 710 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 711 |
DECREASED APPETITE |
18 |
0.0001 |
| 712 |
SWELLING FACE |
5 |
0.0001 |
| 713 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 714 |
ANHEDONIA |
2 |
0.0001 |
| 715 |
OROPHARYNGEAL PAIN |
7 |
0.0001 |
| 716 |
ADVERSE REACTION |
1 |
0.0001 |
| 717 |
BLOOD PRESSURE DECREASED |
5 |
0.0001 |
| 718 |
MALAISE |
33 |
0.0001 |
| 719 |
PNEUMONITIS |
2 |
0.0001 |
| 720 |
MOOD ALTERED |
2 |
0.0001 |
| 721 |
CORONARY ARTERY OCCLUSION |
1 |
0.0001 |
| 722 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 723 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 724 |
VOMITING |
34 |
0.0001 |
| 725 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 726 |
WOUND |
2 |
0.0001 |
| 727 |
MASS |
1 |
0.0001 |
| 728 |
WITHDRAWAL SYNDROME |
3 |
0.0001 |
| 729 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 730 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 731 |
HYPOACUSIS |
3 |
0.0001 |
| 732 |
ACCIDENTAL UNDERDOSE |
1 |
0.0001 |
| 733 |
SEPTIC SHOCK |
3 |
0.0001 |
| 734 |
DYSPHONIA |
4 |
0.0001 |
| 735 |
SURGERY |
4 |
0.0001 |
| 736 |
ANAEMIA |
13 |
0.0001 |
| 737 |
DISEASE PROGRESSION |
8 |
0.0001 |
| 738 |
PULMONARY MASS |
1 |
0.0001 |
| 739 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 740 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 741 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 742 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 743 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 744 |
NAUSEA |
52 |
0.0001 |
| 745 |
INSURANCE ISSUE |
1 |
0.0001 |
| 746 |
HIP ARTHROPLASTY |
1 |
0.0001 |
| 747 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 748 |
ANKLE FRACTURE |
1 |
0.0001 |
| 749 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 750 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 751 |
BRAIN FOG |
1 |
0.0001 |
| 752 |
ARRHYTHMIA |
3 |
0.0001 |
| 753 |
DYSPHAGIA |
6 |
0.0001 |
| 754 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 755 |
DISEASE RECURRENCE |
3 |
0.0001 |
| 756 |
OBESITY |
1 |
0.0001 |
| 757 |
GAIT DISTURBANCE |
12 |
0.0001 |
| 758 |
DRUG DEPENDENCE |
10 |
0.0001 |
| 759 |
NIGHT SWEATS |
2 |
0.0001 |
| 760 |
ATRIAL FIBRILLATION |
6 |
0.0001 |
| 761 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 762 |
DEEP VEIN THROMBOSIS |
4 |
0.0001 |
| 763 |
HYPERTENSION |
13 |
0.0001 |
| 764 |
CHOLELITHIASIS |
2 |
0.0001 |
| 765 |
METASTASES TO BONE |
1 |
0.0001 |
| 766 |
EYE DISORDER |
2 |
0.0001 |
| 767 |
INFUSION RELATED REACTION |
4 |
0.0001 |
| 768 |
LIP SWELLING |
2 |
0.0001 |
| 769 |
FUNGAL INFECTION |
2 |
0.0001 |
| 770 |
GAIT INABILITY |
2 |
0.0001 |
| 771 |
THERAPY CESSATION |
3 |
0.0001 |
| 772 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 773 |
NEOPLASM PROGRESSION |
2 |
0.0001 |
| 774 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 775 |
METASTASES TO LIVER |
1 |
0.0001 |
| 776 |
COLD SWEAT |
1 |
0.0001 |
| 777 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 778 |
MATERNAL EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 779 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 780 |
GOUT |
1 |
0.0001 |
| 781 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 782 |
RESTLESSNESS |
2 |
0.0001 |
| 783 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 784 |
DIZZINESS |
27 |
0.0001 |
| 785 |
NECK PAIN |
3 |
0.0001 |
| 786 |
HYPOAESTHESIA |
8 |
0.0001 |
| 787 |
PRODUCT USE ISSUE |
10 |
0.0001 |
| 788 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 789 |
HALLUCINATION |
4 |
0.0001 |
| 790 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 791 |
FRACTURE |
1 |
0.0001 |
| 792 |
CHRONIC KIDNEY DISEASE |
4 |
0.0001 |
| 793 |
PROTEINURIA |
1 |
0.0001 |
| 794 |
INCREASED APPETITE |
1 |
0.0001 |
| 795 |
BLOOD PRESSURE INCREASED |
8 |
0.0001 |
| 796 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 797 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 798 |
PRODUCT SUBSTITUTION ISSUE |
3 |
0.0001 |
| 799 |
GENERAL PHYSICAL HEALTH DETERIORATION |
6 |
0.0001 |
| 800 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 801 |
EAR PAIN |
1 |
0.0001 |
| 802 |
CHILLS |
6 |
0.0001 |
| 803 |
VISION BLURRED |
7 |
0.0001 |
| 804 |
PARAESTHESIA |
8 |
0.0001 |
| 805 |
DRUG INEFFECTIVE |
67 |
0.0001 |
| 806 |
WHEEZING |
3 |
0.0001 |
| 807 |
DISABILITY |
1 |
0.0001 |
| 808 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 809 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 810 |
WEIGHT DECREASED |
14 |
0.0001 |
| 811 |
FEELING ABNORMAL |
12 |
0.0001 |
| 812 |
PREGNANCY |
1 |
0.0000 |
| 813 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 814 |
PRURITUS |
19 |
0.0000 |
| 815 |
FEEDING DISORDER |
1 |
0.0000 |
| 816 |
DYSKINESIA |
2 |
0.0000 |
| 817 |
DISCOMFORT |
3 |
0.0000 |
| 818 |
NEUTROPHIL COUNT DECREASED |
2 |
0.0000 |
| 819 |
HAEMOGLOBIN DECREASED |
5 |
0.0000 |
| 820 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 821 |
ERYTHEMA |
10 |
0.0000 |
| 822 |
CHEST PAIN |
9 |
0.0000 |
| 823 |
ILLNESS |
5 |
0.0000 |
| 824 |
VISUAL IMPAIRMENT |
6 |
0.0000 |
| 825 |
FALL |
16 |
0.0000 |
| 826 |
ABDOMINAL DISTENSION |
5 |
0.0000 |
| 827 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 828 |
OSTEOARTHRITIS |
2 |
0.0000 |
| 829 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 830 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 831 |
VAGINAL HAEMORRHAGE |
2 |
0.0000 |
| 832 |
CONSTIPATION |
10 |
0.0000 |
| 833 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 834 |
ARTHRALGIA |
19 |
0.0000 |
| 835 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 836 |
GLOSSODYNIA |
1 |
0.0000 |
| 837 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 838 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 839 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 840 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 841 |
HYPOKALAEMIA |
2 |
0.0000 |
| 842 |
RENAL DISORDER |
2 |
0.0000 |
| 843 |
INJURY |
3 |
0.0000 |
| 844 |
PULMONARY EMBOLISM |
4 |
0.0000 |
| 845 |
MULTIPLE SCLEROSIS |
2 |
0.0000 |
| 846 |
MOBILITY DECREASED |
3 |
0.0000 |
| 847 |
HEADACHE |
26 |
0.0000 |
| 848 |
DRUG INTOLERANCE |
4 |
0.0000 |
| 849 |
NEURALGIA |
1 |
0.0000 |
| 850 |
URINARY TRACT INFECTION |
7 |
0.0000 |
| 851 |
LUNG DISORDER |
2 |
0.0000 |
| 852 |
BRONCHITIS |
3 |
0.0000 |
| 853 |
ABASIA |
1 |
0.0000 |
| 854 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 855 |
AGEUSIA |
1 |
0.0000 |
| 856 |
CELLULITIS |
2 |
0.0000 |
| 857 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 858 |
DIABETES MELLITUS |
3 |
0.0000 |
| 859 |
HEPATITIS |
1 |
0.0000 |
| 860 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 861 |
ECZEMA |
2 |
0.0000 |
| 862 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 863 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 864 |
BRADYCARDIA |
2 |
0.0000 |
| 865 |
THROMBOSIS |
3 |
0.0000 |
| 866 |
PAIN OF SKIN |
1 |
0.0000 |
| 867 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 868 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 869 |
DRY MOUTH |
3 |
0.0000 |
| 870 |
OEDEMA |
2 |
0.0000 |
| 871 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 872 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 873 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 874 |
FEELING COLD |
1 |
0.0000 |
| 875 |
PANCYTOPENIA |
2 |
0.0000 |
| 876 |
DIARRHOEA |
23 |
0.0000 |
| 877 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 878 |
PAIN IN JAW |
1 |
0.0000 |
| 879 |
INCORRECT DOSE ADMINISTERED |
8 |
0.0000 |
| 880 |
HYPERSOMNIA |
1 |
0.0000 |
| 881 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
7 |
0.0000 |
| 882 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 883 |
PALPITATIONS |
4 |
0.0000 |
| 884 |
BONE PAIN |
2 |
0.0000 |
| 885 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 886 |
ASCITES |
1 |
0.0000 |
| 887 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 888 |
CATARACT |
2 |
0.0000 |
| 889 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 890 |
INJECTION SITE RASH |
1 |
0.0000 |
| 891 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 892 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 893 |
SWELLING |
3 |
0.0000 |
| 894 |
MIGRAINE |
3 |
0.0000 |
| 895 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 896 |
WEIGHT INCREASED |
7 |
0.0000 |
| 897 |
DYSPEPSIA |
3 |
0.0000 |
| 898 |
IMPAIRED HEALING |
1 |
0.0000 |
| 899 |
DYSPNOEA |
17 |
0.0000 |
| 900 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 901 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 902 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 903 |
EYE PRURITUS |
1 |
0.0000 |
| 904 |
NEUTROPENIA |
4 |
0.0000 |
| 905 |
DRUG EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 906 |
HAEMATURIA |
1 |
0.0000 |
| 907 |
PYREXIA |
10 |
0.0000 |
| 908 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 909 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 910 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 911 |
PNEUMONIA |
9 |
0.0000 |
| 912 |
PAIN |
17 |
0.0000 |
| 913 |
MUSCLE SPASMS |
5 |
0.0000 |
| 914 |
DYSURIA |
1 |
0.0000 |
| 915 |
PAIN IN EXTREMITY |
8 |
0.0000 |
| 916 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 917 |
EPISTAXIS |
2 |
0.0000 |
| 918 |
HOT FLUSH |
2 |
0.0000 |
| 919 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 920 |
INJECTION SITE PAIN |
8 |
0.0000 |
| 921 |
INJECTION SITE HAEMORRHAGE |
2 |
0.0000 |
| 922 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 923 |
JOINT SWELLING |
3 |
0.0000 |
| 924 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 925 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 926 |
BLINDNESS |
1 |
0.0000 |
| 927 |
TREATMENT FAILURE |
2 |
0.0000 |
| 928 |
POLLAKIURIA |
1 |
0.0000 |
| 929 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 930 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 931 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
| 932 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 933 |
COVID-19 |
4 |
0.0000 |
| 934 |
ANGIOEDEMA |
1 |
0.0000 |
| 935 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 936 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 937 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 938 |
DEATH |
19 |
0.0000 |
| 939 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 940 |
ADVERSE EVENT |
2 |
0.0000 |
| 941 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 942 |
BACK PAIN |
5 |
0.0000 |
| 943 |
CARDIAC DISORDER |
2 |
0.0000 |
| 944 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 945 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 946 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 947 |
INFECTION |
3 |
0.0000 |
| 948 |
RASH |
9 |
0.0000 |
| 949 |
PRODUCT DOSE OMISSION ISSUE |
6 |
0.0000 |
| 950 |
DRY EYE |
1 |
0.0000 |
| 951 |
LEUKOPENIA |
1 |
0.0000 |
| 952 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 953 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 954 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 955 |
PANCREATITIS |
1 |
0.0000 |
| 956 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 957 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 958 |
DEPENDENCE |
1 |
0.0000 |
| 959 |
ARTHROPATHY |
1 |
0.0000 |
| 960 |
INFLUENZA |
2 |
0.0000 |
| 961 |
BLISTER |
1 |
0.0000 |
| 962 |
HERPES ZOSTER |
1 |
0.0000 |
| 963 |
EYE IRRITATION |
1 |
0.0000 |
| 964 |
NASAL CONGESTION |
1 |
0.0000 |
| 965 |
EMOTIONAL DISTRESS |
2 |
0.0000 |
| 966 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 967 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 968 |
FEELING HOT |
1 |
0.0000 |
| 969 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 970 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 971 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 972 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 973 |
DYSGEUSIA |
1 |
0.0000 |
| 974 |
ACNE |
1 |
0.0000 |
| 975 |
HOSPITALISATION |
2 |
0.0000 |
| 976 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 977 |
CARDIAC FAILURE |
1 |
0.0000 |
| 978 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 979 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 980 |
BALANCE DISORDER |
1 |
0.0000 |
| 981 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 982 |
BREAST CANCER |
1 |
0.0000 |
| 983 |
COUGH |
3 |
0.0000 |
| 984 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 985 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 986 |
ASTHMA |
1 |
0.0000 |
| 987 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 988 |
PSORIASIS |
1 |
0.0000 |
| 989 |
ALOPECIA |
1 |
0.0000 |